Ixp Lifesciences Catalyst Fund

Beyond Capital

Managed by IXP Lifesciences

IN/AIF1/24-25/1664Cat I

SEBI-encouraged funds — venture capital, SME, social-impact and infrastructure. Close-ended, generally unleveraged.

Overview

About

IXP Lifesciences Catalyst Fund is an early-stage venture capital platform focused on supporting Lifesciences startups from pre-seed to Series A. Built by industry veterans, the fund combines capital with ecosystem support, venture studio capabilities, and deep domain expertise to help scientists and innovators translate research into scalable businesses across biopharma, medical technology, nutraceuticals, cosmeceuticals, and specialty chemicals.

Investment Philosophy

IXP operates as a strategic partner rather than a passive investor, focusing on value creation, collaboration, long-term alignment, and leveraging deep industry expertise. The fund emphasizes tailored support for each startup’s journey, fostering innovation through ecosystem-driven partnerships instead of a one-size-fits-all investment approach.

Team— 7

Ketki Tulpule

Chief Innovation Officer

Techno-commercial professional with 15+ years of experience across Lifesciences, academia, and AI/ML-driven drug discovery. Formerly associated with Rx Propellant, Excelra, Aragen (GVK Bio), and Max Planck Institute.

Vishal Goel

Partner

Co-founder of JV Ventures with 20+ years in Lifesciences, consulting, and infrastructure development. Harvard alumnus with experience across EY, Alexandria Real Estate India, and Red Fort Capital.

Jasmeet Chhabra

Partner

Co-founder of JV Ventures with 20+ years of experience in investment and fundraising. Led capital raising across multiple funds totaling USD 600M+ with deep expertise in investor relations and scaling platforms.

Manoj Nerurkar

Advisor

Pharmaceutical veteran with 25+ years of experience from drug development to commercialization. Former COO of Syngene and leader at Bristol Myers Squibb and Novartis.

Nandu Gattu

Advisor

Expert in bioinformatics, pharmacology, and AI-driven drug discovery with 25+ years of experience across GSK, Excelra, and global research ecosystems.

Nirav Desai

Advisor

Biotechnology expert with 25+ years in biologics, vaccines, and process optimization. Former Head of Vaccines at Cadila Pharmaceuticals with multiple patents.

Atin Tomar

Advisor

Biotech leader with 20+ years of experience across biologics and vaccines. Former CEO of CPL Biologics with academic credentials from IIT Kharagpur, University of Georgia, and ISB.

Registration

SEBI Registration

SEBI-registered

Reg. NumberIN/AIF1/24-25/1664

VintageDec 2024 · 1 yr old

Valid ToPerpetual

Contact PersonKetki Tulpule

AddressNiharika Jubilee One, 4th Floor, P No 1355 H and 1355 I Sy No 120, Road No. 1, Jubilee Hills, Hyderabad, Telangana, 500033, Hyderabad, Telangana, 500033

Insights

No insights published yet.

Disclaimer

Investments in AIFs carry market and credit risk including possible loss of capital. Past performance does not indicate future returns. Information shown is sourced from the issuer's PPM and SEBI filings — confirm against the latest PPM before committing. wisefolio is an information platform; it is not registered with SEBI as an investment adviser, portfolio manager, or distributor. By using this page you accept our terms and privacy policy, including the self-attestation that you are eligible to view AIF marketing material under SEBI rules.